Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer
Clinical trial NCT04030429 · TERMINATED
Trial details
- NCT number
- NCT04030429
- Sponsor
- National Cheng-Kung University Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2025-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.